Publications

Modelling the effect of infection prevention and control measures on rate of Mycobacterium tuberculosis transmission to clinic attendees in primary health clinics in South Africa.

MCCREESH, N; Karat, AS; BAISLEY, K; Diaconu, K; BOZZANI, F; GOVENDER, I; Beckwith, P; Yates, TA; Deol, AK; HOUBEN, RM G J; Kielmann, K; WHITE, RG; GRANT, AD;

2021

BMJ global health, (2021).6 10 10.1136/bmjgh-2021-007124.

Estimating the contribution of transmission in primary healthcare clinics to community-wide TB disease incidence, and the impact of infection prevention and control interventions, in KwaZulu-Natal, South Africa.

MCCREESH, N; Karat, A; GOVENDER, I; BAISLEY, K; Diaconu, K; Yates, T; HOUBEN, RM G J; Kielmann, K; GRANT, A; WHITE, R;

2021

medRxiv (2021). 10.1101/2021.08.02.21260844.

Seroprevalence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers in Kenya.

Etyang, AO; Lucinde, R; Karanja, H; Kalu, C; Mugo, D; Nyagwange, J; Gitonga, J; Tuju, J; Wanjiku, P; Karani, A; Mutua, S; Maroko, H; Nzomo, E; Maitha, E; Kamuri, E; Kaugiria, T; Weru, J; Ochola, LB; Kilimo, N; Charo, S; Emukule, N; Moracha, W; Mukabi, D; Okuku, R; Ogutu, M; ... Warimwe, GM.

2021

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, (2021).74 2 10.1093/cid/ciab346.

Projections of human papillomavirus (HPV) vaccination impact in Ethiopia, India, Nigeria and Pakistan: a comparative modelling study.

Portnoy, A; ABBAS, K; Sweet, S; Kim, JJ; JIT, M;

2021

BMJ Global Health, (2021).6 11 10.1136/bmjgh-2021-006940.

Categorizing Vaccine Confidence With a Transformer-Based Machine Learning Model: Analysis of Nuances of Vaccine Sentiment in Twitter Discourse.

Kummervold, PE; Martin, S; DADA, S; Kilich, E; Denny, C; PATERSON, P; LARSON, HJ;

2021

JMIR Medical Informatics, (2021).9 10 10.2196/29584.

Divergent vaccination policies could fuel mistrust and hesitancy.

Forman, R; JIT, M; Mossialos, E;

2021

Lancet (London, England), (2021).397 10292 10.1016/s0140-6736(21)01106-5.

Impact of BCG revaccination on the response to unrelated vaccines in a Ugandan adolescent birth cohort: randomised controlled trial protocol C for the 'POPulation differences in VACcine responses' (POPVAC) programme.

ZIRIMENYA, L; NKURUNUNGI, G; Nassuuna, J; NATUKUNDA, A; Mutebe, A; Oduru, G; Kabami, G; Akurut, H; Onen, C; Namutebi, M; Serubanja, J; Nakazibwe, E; Akello, F; Tumusiime, J; Sewankambo, M; Kiwanuka, S; Kiwudhu, F; Kizindo, R; Kizza, M; WAJJA, A; COSE, S; Muwanga, M; WEBB, E; ELLIOTT, AM; POPVAC trial team,;

2021

BMJ open, (2021).11 2 10.1136/bmjopen-2020-040430.

Impact of the Covid-19 epidemic and related social distancing regulations on social contact and SARS-CoV-2 transmission potential in rural South Africa: analysis of repeated cross-sectional surveys.

MCCREESH, N; Dlamini, V; Edwards, A; Olivier, S; Dayi, N; Dikgale, K; Nxumalo, S; Dreyer, J; BAISLEY, K; Siedner, MJ; WHITE, RG; Herbst, K; GRANT, AD; Harling, G;

2021

BMC infectious diseases, (2021).21 1 10.1186/s12879-021-06604-8.

Levels of pneumococcal conjugate vaccine coverage and indirect protection against invasive pneumococcal disease and pneumonia hospitalisations in Australia: An observational study.

Chan, J; Gidding, HF; Blyth, CC; Fathima, P; Jayasinghe, S; McIntyre, PB; Moore, HC; MULHOLLAND, K; Nguyen, CD; Andrews, R; Russell, FM;

2021

PLoS medicine, (2021).18 8 10.1371/journal.pmed.1003733.

Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study.

Debellut, F; CLARK, A; Pecenka, C; Tate, J; Baral, R; SANDERSON, C; Parashar, U; Atherly, D;

2021

The Lancet. Global health, (2021).9 7 10.1016/S2214-109X(21)00167-4.